Medicare Part D coverage · tadalafil · RxCUI 2613569
tadalafil 4 MG/ML Oral Suspension [Tadliq]
Per the CMS 2026 Part D formulary file, tadalafil 4 MG/ML Oral Suspension [Tadliq] is covered by 33 Medicare Part D plans (0.7% of enrollable products), averaging Tier 4.3, with prior authorization required on 100% of covering formularies.
- 0.7%
- Plan coverage
- 33
- Plans covering
- T4.3
- Avg tier
- 100%
- Prior auth required
What the CMS Formulary Data Shows for tadalafil 4 MG/ML Oral Suspension [Tadliq]
Per the CMS 2026 Part D formulary file, tadalafil 4 MG/ML Oral Suspension [Tadliq] (RxNorm concept RXCUI 2613569, generic name tadalafil) appears on 16 distinct formulary files spanning 33 Medicare Part D plan offerings - 0.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.3.
Real-world access to tadalafil 4 MG/ML Oral Suspension [Tadliq] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 75% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 74,638 Part D beneficiaries filled tadalafil 4 MG/ML Oral Suspension [Tadliq] in 2023, with total plan-and-beneficiary spending of $95,218,190 and an average per-beneficiary annual cost of $1,275.73. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tadalafil 4 MG/ML Oral Suspension [Tadliq] today.
Coverage Details
- Formularies covering
- 16
- Plans covering
- 33
- Coverage rate
- 0.7%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 75% of formularies
2023 Medicare Spending
- Beneficiaries
- 74,638
- Total spending
- $95,218,190
- Avg per beneficiary
- $1,275.73
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering tadalafil 4 MG/ML Oral Suspension [Tadliq]
33 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | UT |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Essential (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Flex (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare + Kroger (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Active (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | CO |
| Select Health Medicare Dual (HMO D-SNP) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Select Health Medicare Wellness (HMO) | Selecthealth, Inc. | T5 | Yes | $0 | NV |
| Troy Medicare (HMO) | Troy Health, Inc. | T5 | Yes | $0 | NC |
| Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) | Troy Health, Inc. | T5 | Yes | $0 | NC |
Show the next 13 plans
| Contra Costa Health Care Plus (HMO D-SNP) | Contra Costa County Medical Service DBA Contra Costa Health | T5 | Yes | $0 | CA |
| Keystone First VIP Choice (HMO D-SNP) | Vista Health Plan, Inc. | T5 | Yes | $0 | PA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Vista Health Plan, Inc. | T5 | Yes | $0 | PA |
| First Choice VIP Care (HMO D-SNP) | Select Health OF South Carolina, Inc. | T5 | Yes | $0 | SC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T5 | Yes | $0 | DE |
| AmeriHealth Caritas VIP Care Choice (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T5 | Yes | $0 | DE |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Florida, Inc. | T5 | Yes | $0 | FL |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Louisiana, Inc. | T5 | Yes | $0 | LA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas North Carolina, Inc. | T5 | Yes | $0 | NC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Michigan, Inc. | T5 | Yes | $0 | MI |
| Healthy Mississippi Premier Advantage (HMO-POS) | Healthy Mississippi, Inc. | T5 | Yes | $0 | MS |
| CareOregon Advantage Plus (HMO D-SNP) | Health Plan OF Careoregon, Inc. | T5 | Yes | $0 | OR |
| Samaritan Dual Advantage (HMO D-SNP) | Samaritan Health Plans, Inc. | T5 | Yes | $10.50 | OR |
Frequently Asked Questions
Is tadalafil 4 MG/ML Oral Suspension [Tadliq] covered by Medicare Part D?
Yes, tadalafil 4 MG/ML Oral Suspension [Tadliq] is covered by 33 Medicare Part D plans (0.7% of all Part D formularies).
What tier is tadalafil 4 MG/ML Oral Suspension [Tadliq] on Medicare Part D plans?
tadalafil 4 MG/ML Oral Suspension [Tadliq] averages Tier 4.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does tadalafil 4 MG/ML Oral Suspension [Tadliq] require prior authorization?
100% of Part D formularies require prior authorization for tadalafil 4 MG/ML Oral Suspension [Tadliq]. Step therapy: 0%. Quantity limits: 75%.
How much does Medicare spend on tadalafil 4 MG/ML Oral Suspension [Tadliq]?
In 2023, total Medicare Part D spending on tadalafil 4 MG/ML Oral Suspension [Tadliq] was $95,218,190, covering 74,638 beneficiaries. The average spend per beneficiary was $1,275.73.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- azathioprine 50 MG Oral Tablet 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- sotagliflozin 200 MG Oral Tablet [Inpefa] 100% PA
- mycophenolate mofetil 250 MG Oral Capsule 100% PA